Search

everythinglearnresearchcommunity

for

Search:↓

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

New, safer, and personalized treatments are needed for oral lichen planus.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Fumaric acid esters, especially dimethylfumarate, improve psoriasis treatment.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.